Vanta Bioscience receives GLP compliance re-certification
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The FDA issued Form 483 with one observation related to building and facility management
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
Alembic Pharmaceuticals commissions new facility at Pithampur
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
ekincare has raised a total funding of $22M since 2015 till date
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Subscribe To Our Newsletter & Stay Updated